News | April 11, 2023
Astec LifeSciences launches Rs. 100 crore Adi Godrej Center for Chemical Research and Development
To enable company to be future-ready by tapping potential in CDMO space
To enable company to be future-ready by tapping potential in CDMO space
Envelta is the company’s non-opioid pain product candidate for acute and chronic pain
He mentioned that Thyroid disorders are a common health problem in Jammu and Kashmir
Bourgoin early development hub broadens offerings for oral solid dose formulations
It provides doctors with three indicators: identification of the bone, confirmation of device insertion into the bone, and notification in case of perforation through the opposite end of the bone
The Award acknowledges Emcure's contribution in the field of HIV/AIDS to improve the quality of life of people living with HIV/AIDS.
Microsoft Cloud for Healthcare and Cognizant’s TriZetto healthcare products aim to enhance transparency for consumers and increase interoperability for providers and payers
The introduction of Octasa 1600 mg to the Canadian market is expected to increase the options for UC patients managed with mesalazine.
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial and unmet need for additional therapeutic options for certain types of melanoma
Subscribe To Our Newsletter & Stay Updated
